COVID-19: Supporting the vaccine rollout

We're planning the infrastructure, logistics, training and technology to support New Zealand’s largest immunisation programme.

Last updated: 28 May 2021

On this page:


COVID-19 vaccine – protecting Aotearoa (PDF, 403 KB)

Vaccine strategy

New Zealand’s COVID-19 Vaccine Strategy uses expertise from across the government. It sets the steps we must take so we have the infrastructure, regulations and relationships in place for COVID-19 vaccines.

COVID-19 Vaccine strategy
New Zealand’s elimination strategy
COVID-19 Communications and engagement approach (PDF, 4.55MB)

Immunisation programme

Vaccines will be rolled out through a COVID-19 Immunisation Programme. This will be New Zealand’s largest immunisation rollout ever. We’ve never attempted an immunisation programme of this scale, cost or complexity.

Our vaccine rollout plan

Accessing the vaccine

We’re committed to putting in place the right systems and services, so it’s easy and convenient for everyone aged 16 and over to get a COVID-19 vaccine.

We aren’t offering the Pfizer vaccine to those aged 16 and under until further data is available.

We’re working with organisations across the health and disability system to make it easy for New Zealanders to be vaccinated and ensure people are well informed and supported when accessing a vaccine.

Where vaccinations will happen

Ensuring equal access

Ensuring equal access to free COVID-19 vaccines is a priority for New Zealand.

The Government is committed to upholding and honouring Te Tiriti o Waitangi, including obligations towards Māori that flow from the Treaty partnership. We have a strong focus on:

  • partnership
  • tino rangatiratanga
  • options
  • equity
  • active protection. 

Working with our partners

We’re working closely with higher risk communities, Māori and our Pacific neighbours to ensure we’re providing equal and fair access to the COVID-19 vaccine.

Who we’re working with

Scaling up the workforce

Outside our regular vaccination workforce of general practitioners, nurses and pharmacists we’re planning for an extra 1,600 full-time equivalent vaccinators. They’ll be trained and available when needed throughout New Zealand. 

The workforce will continue to scale up during 2021 in line with vaccine delivery schedules.

Recruitment and training

We’re working with other partners across the health and disability system to engage additional vaccinator capacity across New Zealand. DHBs are assessing their current capacity to vaccinate within their regions.

Vaccinators can be sourced from:

  • medical students
  • nursing students
  • anaesthetic technicians
  • dentists
  • doctors
  • enrolled nurses
  • medical imaging/radiation therapists
  • medical laboratory scientists
  • midwives
  • nurse practitioners
  • nurses
  • occupational therapists
  • optometrists
  • paramedics
  • pharmacists
  • physiotherapists, and
  • speech language therapists.

Join the COVID-19 vaccination teams

We’re seeking interest from those who’d like to be part of the COVID-19 vaccination workforce.

Both paid and volunteer opportunities are available in various locations, and we’re looking for skills from both health and non-health backgrounds.

Read more about joining the workforce

COVID-19 vaccine training

The Immunisation Advisory Centre will provide training on the COVID-19 vaccines. This is expected to start in February 2021 and will be available online as well as face-to-face, across the country.

Immunisation Advisory Centre

Infrastructure and logistics

Over $66 million has been allocated to support the roll out of the vaccine. Most of this investment is to pay for enough supplies to vaccinate our entire population and support our Pacific Realm countries.

Medical supplies

This includes, for example, personal protective equipment (PPE), needles, syringes and swabs.

Freezer storage and distribution

We’ve purchased nine large -80°C freezers that can store more than 1.5 million doses of vaccine. These will become our central storage facility for the vaccine that requires ultra-low temperatures (the Pfizer/BioNTech vaccine).

We plan to distribute vaccines from our central storage facilities in a very controlled way to our cold chain network nationwide.

Work is underway to assess what expansion is needed to our cold chain nationwide to make sure we’re ready to distribute the COVID-19 vaccine across the country. Some vaccines can be stored for up to five days in normal cold chain fridges in temperatures from 2-8°C.

Technology and systems

Immunisation register

The National Immunisation Register (NIR) hold records for all immunisations given to children in New Zealand, as well as some adults. We’re developing a replacement NIR system – the National Immunisation Solution (NIS).

NIS will allow health workers to record vaccinations anywhere, anytime. The public will be able to digitally access their own immunisation records.

The first iteration of the system will be available to fully support a COVID-19 vaccine rollout and additional functionality will be added through further iterations.

Inventory management system

We’re developing an inventory management system for COVID-19 vaccines. This will hold information about where the vaccines are located, as well as volumes and temperature.

The system will help us track and trace COVID-19 vaccines and consumables, including their expiry dates to minimise wastage.

In this section

Back to top